Fan, B. and Wang, M. 2022. Ruxolitinib, a JAK1/2 Inhibitor as Treatment for Paraneoplastic Pemphigus: A Case Report. Acta Dermato-Venereologica. 102, (Jun. 2022), adv00732. DOI:https://doi.org/10.2340/actadv.v102.1378.